期 |
栏目 |
标题 |
文件 |
卷 93, 编号 11 (2021) |
Original articles |
The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial |
(Rus)
|
卷 96, 编号 5 (2024) |
Original articles |
Efficacy and safety of undenatured type II collagen in patients with knee osteoarthritis: a multicenter, prospective, double-blind, placebo-controlled, randomized trial |
(Rus)
|
卷 96, 编号 1 (2024) |
Consensuns |
Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D3 in knee osteoarthritis: a resolution of the Expert panel |
(Rus)
|
卷 95, 编号 12 (2023) |
Original articles |
Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint |
(Rus)
|